疫苗评估的核心价值
当前多数健康经济模型未能充分纳入疫苗相关疾病特异性标准与获益属性,疫苗评估方法标准化和透明度不足。作者基于德尔菲技术开展两项研究,调查全球疫苗领域多元背景专家,确定四个高度一致的属性:每年预防的疾病病例数、成本效果、高死亡率疾病和靶疾病严重程度。
要点
- 两项德尔菲研究确定四个疫苗评估核心价值属性。
- 核心属性包括每年预防病例数、成本效果、高死亡率和疾病严重程度。
- 结果提示就特定核心价值集达成明确共识具有可行性。
核心结论
- 结果提示就疫苗评估的特定核心价值集达成明确共识具有可行性。
研究设计与样本
- 基于德尔菲技术开展两项研究,调查全球疫苗领域多元专业背景专家组成的队列。
主要发现
- 两项研究的正式统计分析确定四个高度一致的属性:每年预防的疾病病例数、成本效果、高死亡率疾病和靶疾病严重程度。
关键数值与推荐
- 每年预防的疾病病例数。
- 成本效果(包括成本-效益和成本-效用分析)。
- 高死亡率疾病(病死率)。
- 靶疾病严重程度(发病和死亡风险)。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Currently, most health economic modelling approaches tend to inadequately incorporate crucial disease-specific criteria and other attributes of benefit resulting from vaccination, which limits their utility for evaluating vaccines and, in consequence, for optimally guiding vaccine decision-making. Additionally, vaccine evaluation methods are frequently poorly standardised and non-transparent, leading to a potentially low level of accountability that can hinder acceptance of resulting decisions. To address these issues, we have considered whether it is possible to identify a set of universal vaccine-disease considerations, which we have called Core Values. To begin to identify such a set of criteria, and to establish whether strong agreement around such core values exists, we conducted two studies based on the Delphi technique. Both studies surveyed a cohort consisting of expert members of the global vaccine community with diverse professional backgrounds. Formal statistical analysis of both studies identified four attributes with strong agreement: 1. Incidence disease cases prevented per year, 2. Cost-effectiveness (including cost-benefit and cost-utility analysis), 3. High mortality disease (case-fatality-rate), and 4. Severity of target disease (risk of morbidity and mortality). These results suggest the feasibility of identifying a clear consensus on a specific set of Core Values for Vaccine Evaluation.
引用
- Timmis JK, Rigat F, Rappuoli R, et al. Core values for vaccine evaluation. Vaccine. 2016. PMID: 28017445. doi:10.1016/j.vaccine.2016.11.034
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。